Radford Jason W. 4
4 · GENOMIC HEALTH INC · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Radford Jason W.
Chief Legal Officer
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2019-11-08−12,000→ 0 totalExercise: $27.85Exp: 2025-05-18→ Common Stock (12,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−9,643→ 877 totalExercise: $27.00Exp: 2026-02-16→ Common Stock (9,643 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−18,095→ 8,225 totalExercise: $27.48Exp: 2027-01-31→ Common Stock (18,095 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−19,485→ 0 totalExercise: $33.21Exp: 2028-01-31→ Common Stock (19,485 underlying) - Disposition to Issuer
Common Stock
2019-11-08−20,924→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−15,155→ 19,485 totalExercise: $33.21Exp: 2028-01-31→ Common Stock (15,155 underlying) - Disposition to Issuer
Common Stock
2019-11-08−8,384→ 20,924 total - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−877→ 0 totalExercise: $27.00Exp: 2026-02-16→ Common Stock (877 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−8,225→ 0 totalExercise: $27.48Exp: 2027-01-31→ Common Stock (8,225 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−16,270→ 0 totalExercise: $72.52Exp: 2029-01-29→ Common Stock (16,270 underlying)
Footnotes (10)
- [F1]Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $230,595 and 3,776 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F10]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 12,451 shares of Exact Sciences common stock with an exercise price of $94.76 per share.
- [F2]Disposed of in connection with the Merger, whereby such Issuer restricted stock unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 16,013 RSUs of Exact Sciences common stock, having a market value of $79.95 based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F3]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $192,492, less applicable tax withholdings, and 3,152 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F4]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $158,056, less applicable tax withholdings, and 2,588 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F5]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 671 shares of Exact Sciences common stock with an exercise price of $35.28 per share.
- [F6]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $293,016, less applicable tax withholdings, and 4,799 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F7]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 6,294 shares of Exact Sciences common stock with an exercise price of $35.91 per share.
- [F8]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $209,678, less applicable tax withholdings, and 3,434 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F9]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 14,912 shares of Exact Sciences common stock with an exercise price of $43.40 per share.